Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001902207 | SCV002130864 | pathogenic | not provided | 2021-03-16 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Asp17Glyfs*28) in the VPS13A gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in VPS13A are known to be pathogenic (PMID: 12404112, 21598378). This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals with VPS13A-related conditions. For these reasons, this variant has been classified as Pathogenic. |